Rose C Perri Net Worth & Insider Trades

Rose C Perri - Director, Generex Biotechnology Corp

As of May 11, 2011

What is Rose C Perri's Net Worth?

The current estimated net worth of Generex Biotechnology Corp's Director, Rose C Perri, is estimated to be about $13.65K . Rose C Perri owns about 1,929,145 units of Generex Biotechnology Corp common stock. In the last 8 years at Generex Biotechnology Corp, Rose C Perri has sold an estimated value of $13.45K worth.

What is Rose C Perri's Past Insider Trading?

Rose C Perri's largest purchase order was 54,000 units , worth over $18.9K on October 27, 2010. Rose C Perri's largest sale order was 25,000 units , worth over $5.5K on May 4, 2011. In total, Rose C Perri has made about 16 transactions over 8 years of their time at Generex Biotechnology Corp. Rose C Perri usually trades in November, with the busiest year in 2003. The most recent transaction was a sale order of 15,000 units , worth over $3.45K on May 11, 2011.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Rose C Perri's' Mailing Address?

  • Mailing address is 33 Harbour Square Ste 202 Toronto Ontario Canada M5h2g2 A1 00000 British Columbia, Canada

What are Generex Biotechnology Corp's Past Insider Trades?

Generex Biotechnology Corp's most recent insider trade came on December 14, 2018 by Harold Gray Haines who bought 1,500 units worth $3.17K . In the last 15 years, insiders at Generex Biotechnology Corp have sold an estimated value of $443.18K and bought an estimated value of $736.47K worth of shares. Insider trading is most common in November and June, with the busiest year in 2013. The most active traders at the company are Mark Fletcher, EVP General Counsel &Secretary,  Rose C Perri, Director,  and Brian McGee, Director .

GENEREX BIOTECHNOLOGY CORP Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1